In addition to the three NPVs, the FDA also announced the approval of an IND submission for DemeRx, which is investigating ...

Last month marked Women’s History Month, and in February there was International Day of Women and Girls in Science, too. But, ...

Every January, thousands of pharma and biotech executives, analysts, and journalists descend on Union Square in San Francisco for a sprawling industry gathering that has less to do each year with its ...

Oligonucleotide (oligo) therapies have been in development for decades. Recent advances in molecular design, chemistry, ...

GSK has turned to China’s Hansoh Pharma to add another antibody-drug conjugate (ADC) to its oncology pipeline, this time licensing a B7-H3-targeting candidate for $185 million upfront. The new deal – ...

Clinical trial sponsors and contract research organisations (CROs) are expanding clinical trials internationally to access ...

Regeneron has become the first company to get US approval for a gene therapy for congenital hearing loss, after the FDA gave ...

The regulator has sent a complete response letter (CRL) to AbbVie for trenibotulinumtoxinE (TrenibotE), a follow-up to its ...

Armed with new phase 3 data, Novo Nordisk has said it will file for approval of oral formulations of its GLP-1 agonist ...

The first volunteers in a large-scale trial of Moderna's mRNA-based vaccine against bird flu – long considered to be a ...

Last year's $2.5 billion acquisition of Dynavax started to deliver, with a 2.1% rise in vaccine sales to €1.3 billion, driven ...

MSD's announcement is a fillip for Google Cloud early on in the rollout of Gemini Enterprise as it competes in the ...